Literature DB >> 33439022

Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.

Takeshi Terada1, Jayesh A Kulkarni1, Ariel Huynh1, Sam Chen1, Roy van der Meel1, Yuen Yi C Tam1, Pieter R Cullis1.   

Abstract

Lipid nanoparticles (LNPs) containing short-interfering RNA (LNP-siRNA systems) are a promising approach for silencing disease-causing genes in hepatocytes following intravenous administration. LNP-siRNA systems are generated by rapid mixing of lipids in ethanol with siRNA in aqueous buffer (pH 4.0) where the ionizable lipid is positively charged, followed by dialysis to remove ethanol and to raise the pH to 7.4. Ionizable cationic lipids are the critical excipient in LNP systems as they drive entrapment and intracellular delivery. A recent study on the formation of LNP-siRNA systems suggested that ionizable cationic lipids segregate from other lipid components upon charge neutralization to form an amorphous oil droplet in the core of LNPs. This leads to a decrease in intervesicle electrostatic repulsion, thereby engendering fusion of small vesicles to form final LNPs of increased size. In this study, we prepared LNP-siRNA systems containing four lipid components (hydrogenated soy phosphatidylcholine, cholesterol, PEG-lipid, and 1,2-dioleoyl-3-dimethylammonium propane) by microfluidic mixing. The effects of preparation parameters [lipid concentration, flow rate ratio (FRR), and total flow rate], dialysis process, and complex formation between siRNA and ionizable cationic lipids on the physicochemical properties [siRNA entrapment on the particle size and polydispersity index (PDI)] were investigated using a design of experiments approach. The results for the preparation parameters showed no impact on siRNA encapsulation, but lipid concentration and FRR significantly affected the particle size and PDI. In addition, the effect of FRR on the particle size was suppressed in the presence of anionic polymers such as siRNA as compared to the case of LNPs alone. More intriguingly, unlike empty LNPs, a decrease in the PDI and an increase in the particle size occurred after dialysis in the LNP-siRNA systems. Such changes by dialysis were suppressed at FRR = 1. These findings provide useful information to guide the development and manufacturing conditions for LNP-siRNA systems.

Entities:  

Year:  2021        PMID: 33439022     DOI: 10.1021/acs.langmuir.0c03039

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  12 in total

1.  Optimal self-assembly of lipid nanoparticles (LNP) in a ring micromixer.

Authors:  Manon Ripoll; Elian Martin; Mathilde Enot; Oscar Robbe; Chiara Rapisarda; Marie-Claire Nicolai; Aurélie Deliot; Patrick Tabeling; Jean-René Authelin; Mostafa Nakach; Pierre Wils
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

2.  Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach.

Authors:  Han Han Ly; Simon Daniel; Shekinah K V Soriano; Zoltán Kis; Anna K Blakney
Journal:  Mol Pharm       Date:  2022-05-23       Impact factor: 5.364

Review 3.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881

Review 4.  Delivery Strategies for mRNA Vaccines.

Authors:  Sivakumar Ramachandran; Soumya Ranjan Satapathy; Tathagata Dutta
Journal:  Pharmaceut Med       Date:  2022-01-30

Review 5.  Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.

Authors:  Masatoshi Maeki; Shuya Uno; Ayuka Niwa; Yuto Okada; Manabu Tokeshi
Journal:  J Control Release       Date:  2022-02-17       Impact factor: 9.776

6.  Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.

Authors:  Haidar Saify Nabiabad; Massoume Amini; Serwet Demirdas
Journal:  Chem Biol Drug Des       Date:  2021-11-24       Impact factor: 2.873

Review 7.  The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.

Authors:  Laura Taina-González; María de la Fuente
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

8.  Microfluidic-Based Cationic Cholesterol Lipid siRNA Delivery Nanosystem: Highly Efficient In Vitro Gene Silencing and the Intracellular Behavior.

Authors:  Zhaoyuan Zhu; Li Zhang; Ruilong Sheng; Jian Chen
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

9.  Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques.

Authors:  Natalia Markova; Stefan Cairns; Hanna Jankevics-Jones; Michael Kaszuba; Fanny Caputo; Jérémie Parot
Journal:  Vaccines (Basel)       Date:  2021-12-30

10.  A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers.

Authors:  Simone R Castro; Lígia N M Ribeiro; Márcia C Breitkreitz; Viviane A Guilherme; Gustavo H Rodrigues da Silva; Hery Mitsutake; Ana C S Alcântara; Fabiano Yokaichiya; Margareth K K D Franco; Daniel Clemens; Ben Kent; Marcelo Lancellotti; Daniele R de Araújo; Eneida de Paula
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.